BR0215700A - Método para medir a quantidade de proteìna de beta ig-h3 e kit diagnóstico empregando o mesmo - Google Patents

Método para medir a quantidade de proteìna de beta ig-h3 e kit diagnóstico empregando o mesmo

Info

Publication number
BR0215700A
BR0215700A BR0215700-4A BR0215700A BR0215700A BR 0215700 A BR0215700 A BR 0215700A BR 0215700 A BR0215700 A BR 0215700A BR 0215700 A BR0215700 A BR 0215700A
Authority
BR
Brazil
Prior art keywords
protein
measuring
amount
diagnostic kit
same
Prior art date
Application number
BR0215700-4A
Other languages
English (en)
Inventor
In-San Kim
Jong-Sub Bae
Original Assignee
Regen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020020021488A external-priority patent/KR100609006B1/ko
Application filed by Regen Biotech Inc filed Critical Regen Biotech Inc
Publication of BR0215700A publication Critical patent/BR0215700A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"MéTODO PARA MEDIR A QUANTIDADE DE PROTEìNA DE BETA ig-h3 E KIT DIAGNóSTICO EMPREGANDO O MESMO". A presente invenção refere-se ao método para medir a quantidade de proteína de <225>ig-h3 e Kit diagnóstico empregando o mesmo. Particularmente, ela refere-se ao método para medir a quantidade de proteína <225> ig-h3 nos fluidos corporais por reação de ligação específica entre a proteína <225> ig-h3 ou proteínas recombinantes de domínio de fas-1 na proteína de <225> igh3 (incluindo seus fragmentos ou seus derivados) e seus ligandos e referese a Kit diagnóstico para as doenças renais, doenças hepáticas, artrite reumatóide ou doenças cardiovasculares compreendendo proteína de <225> ig-h3 ou proteínas recombinantes de domínio de fas-1 na proteína de <225> ig-h3 (incluindo seus fragmentos ou seus derivados) e seus ligandos. O método e Kit da presente invenção pode ser eficazmente empregado como método diagnóstico sensível para a extensão de dano ou progresso das doenças renais, doenças hepáticas, artrite reumatóide ou doenças cardiovasculares.
BR0215700-4A 2002-04-19 2002-10-22 Método para medir a quantidade de proteìna de beta ig-h3 e kit diagnóstico empregando o mesmo BR0215700A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020021488A KR100609006B1 (ko) 2001-04-19 2002-04-19 βｉｇ­ｈ３ 단백질의 정량방법 및 이를 이용한 진단킷트
PCT/KR2002/001975 WO2003089935A1 (en) 2002-04-19 2002-10-22 THE METHOD FOR MEASURING THE AMOUNT OF βiG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME

Publications (1)

Publication Number Publication Date
BR0215700A true BR0215700A (pt) 2005-05-03

Family

ID=29244753

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215700-4A BR0215700A (pt) 2002-04-19 2002-10-22 Método para medir a quantidade de proteìna de beta ig-h3 e kit diagnóstico empregando o mesmo

Country Status (8)

Country Link
US (1) US20050164197A1 (pt)
EP (1) EP1502114A4 (pt)
JP (1) JP2005527813A (pt)
CN (1) CN100374864C (pt)
AU (1) AU2002348583B2 (pt)
BR (1) BR0215700A (pt)
RU (1) RU2281512C2 (pt)
WO (1) WO2003089935A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060056445A (ko) * 2004-11-19 2006-05-24 주식회사 리젠 바이오텍 인간 βｉｇ－ｈ３에 대한 단클론 항체
CA2633255A1 (en) * 2005-12-16 2007-06-21 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
ES2944259T3 (es) * 2016-03-15 2023-06-20 Inst Nat Sante Rech Med Procedimiento para activar la respuesta antitumoral de linfocitos T CD8+ de un paciente afectado con un cáncer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
IT1213254B (it) * 1984-12-06 1989-12-14 Boehringer Biochemia Srl Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
US4640909A (en) * 1985-05-07 1987-02-03 J. T. Baker Chemical Company Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction
US5444164A (en) * 1992-02-05 1995-08-22 Bristol-Myers Squibb Company TGF-β induced gene
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5599788A (en) * 1994-07-01 1997-02-04 Advanced Tissue Sciences Method for accelerating skin wound healing with H3 protein
KR100385293B1 (ko) * 2000-05-13 2003-05-23 주식회사 리젠 바이오텍 βｉｇ-ｈ3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법
JP2004522980A (ja) * 2000-11-16 2004-07-29 シファーゲン バイオシステムズ， インコーポレイテッド 質量スペクトルを分析する方法

Also Published As

Publication number Publication date
US20050164197A1 (en) 2005-07-28
CN100374864C (zh) 2008-03-12
JP2005527813A (ja) 2005-09-15
WO2003089935A1 (en) 2003-10-30
RU2004133806A (ru) 2005-04-20
EP1502114A4 (en) 2006-06-07
CN1625687A (zh) 2005-06-08
AU2002348583B2 (en) 2006-12-07
RU2281512C2 (ru) 2006-08-10
EP1502114A1 (en) 2005-02-02
AU2002348583A1 (en) 2003-11-03

Similar Documents

Publication Publication Date Title
DK1948235T3 (da) Fremgangsmåder til bestemmelse af effektiviteten af adalimumab hos patienter med Bechterews sygdom med CTX-II og MMP3 som biomarkører
BRPI9910394B1 (pt) molÉculas de ligaÇço especÍfica para cintigrafia e conjugados contendo as mesmas
BRPI0518994A2 (pt) anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
WO2002054081A3 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
DE69933661D1 (de) Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
EP1495133A4 (en) BINDING PROTEINS AS BIOSENSORS
ATE443161T1 (de) Mittel und verfahren für den nachweis von methylierter dna
ME00783B (me) Kit za radioobilježavanje proteina sa itrijumom-90
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
WO2011150994A3 (en) Serum and tissue biomarkers of human hcc
WO2007061988A3 (en) Methods for determining notch signaling and uses thereof
EP2083018A3 (en) Compositions and methods relating to STOP-1
BR0215700A (pt) Método para medir a quantidade de proteìna de beta ig-h3 e kit diagnóstico empregando o mesmo
WO2005036127A3 (en) Methods and compositions for identifying target cell cytolytic lymphocytes in a sample
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
DE60012713D1 (de) Durch xanthurensäure modifizierte proteine
Morita et al. Stabilities of N-acetyl-β-D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications
EP1898938A4 (en) LIQUID PROTEIN MARKERS FOR NATIVE GEL ELECTROPHORESIS
AU2003262727A1 (en) Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents
Iwaki-Egawa et al. Characterization and purification of adenosine deaminase 1 from human and chicken liver
NO993653D0 (no) Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
WO2007002739A3 (en) Chromium-amino acid complexes in the treatment of diabetes and other diseases
WO2001063293A8 (en) Diagnosis and treatment of schizophrenia

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.